American International Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-17,982
Closed -$1.07M 3132
2020
Q2
$1.07M Buy
17,982
+7,090
+65% +$438K 0.01% 1185
2020
Q1
$647K Sell
10,892
-629
-5% -$36.7K ﹤0.01% 1303
2019
Q4
$631K Buy
11,521
+3,064
+36% +$114K ﹤0.01% 1566
2019
Q3
$239K Sell
8,457
-59
-0.7% -$2.16K ﹤0.01% 2066
2019
Q2
$283K Buy
8,516
+4,874
+134% +$152K ﹤0.01% 2019
2019
Q1
$124K Sell
3,642
-118
-3% -$3.75K ﹤0.01% 2500
2018
Q4
$103K Buy
+3,760
New +$96.9K ﹤0.01% 2580

Other funds holding PRNB

American International Group's PRNB Position: Q3 2020 in Review

American International Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 17,982 shares — an estimated $1.07M sold.

American International Group first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $1.07M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • American International Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • American International Group sold 17,982 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $1.07M.
  • American International Group first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • American International Group's Principia Biopharma Inc. Common Stock position peaked at $1.07M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on American International Group's 13F filing for Q3 2020, filed 4 Nov 2020.